Encompass Health (EHC) reported Q3 adjusted earnings late Monday of $1.03 per diluted share, up from $0.86 a year earlier.
Analysts polled by Capital IQ expected $0.94.
Net operating revenue for the quarter ended Sept. 30 increased to $1.35 billion from $1.21 billion a year earlier.
Analysts surveyed by Capital IQ expected $1.33 billion.
For 2024, the company now expects adjusted EPS of $4.19 to $4.33 on revenue of $5.33 billion to $5.38 billion, up from its prior ranges of $3.97 to $4.22 and $5.28 billion to $5.35 billion.
The consensus is for $4.19 and $5.32 billion, respectively.
Shares of Encompass Health were up more than 5% in after-hours trading.
Price: 98.00, Change: +4.91, Percent Change: +5.27
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.